Journal
BIOCHEMISTRY
Volume 56, Issue 19, Pages 2497-2505Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.biochem.7b00257
Keywords
-
Categories
Funding
- UK charities BRACE
- Alzheimer's Research UK [ARUK-PG2012-1]
- Alzheimers Research UK [ARUK-PG2012-1] Funding Source: researchfish
Ask authors/readers for more resources
a-Synuclein (alpha-syn) is a cytosolic protein known for its association with neurodegenerative diseases, including Parkinson's disease and other synucleinopathies. The potential cellular function of a-synuclein may be of consequence for understanding the pathogenesis of such diseases. Previous work has suggested that a-synuclein can catalyze the reduction of iron as a ferrireductase. We performed a detailed analysis of the steady-state kinetics of recombinant a-syn ferrireductase activity and for disease associated variants. Our study illustrates that the ferrireductase activity we observed is clearly commensurate with bona fide enzyme activity and suggests a mechanistic rationale for the activity and the relationship to cellular regulation of the pool of Fe(III) and Fe(II). Using cell-based studies, we examined the functionally active conformation and found that the major catalytically active form is a putative membrane-associated tetramer. Using an artificial membrane environment with recombinant protein, we demonstrate that secondary structure folding of a-synuclein is insufficient to allow enzyme activity and the absolute specificity of the tertiary/quaternary structure is the primary requirement. Finally, we explored the steady-state kinetics of a range of disease alpha-synuclein variants and found that variants involved in neurodegenerative disease exhibited major changes in their enzymatic activity. We discuss these data in the context of a potential disease-associated mechanism for aberrant a-synuclein ferrireductase activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available